Nowicka, P.
Ek, A.
Jurca-Simina, I. E.
Bouzas, C.
Argelich, E.
Nordin, K.
García, S.
Vasquez Barquero, M. Y.
Hoffer, U.
Reijs Richards, H.
Tur, J. A.
Chirita-Emandi, A.
Eli, K.
Funding for this research was provided by:
Horizon 2020 Framework Programme (774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2, 774548 – STOP - H2020-SFS-2016-2017/H2020-SFS-2017-2)
Center for Innovative Medicine (SLL20190383)
Instituto de Salud Carlos III (CIBEROBN CB12/03/30038, CIBEROBN CB12/03/30038, CIBEROBN CB12/03/30038)
Uppsala University
Article History
Received: 12 December 2021
Accepted: 3 May 2022
First Online: 17 May 2022
Declarations
:
: The study was approved by the Ethics Committee of Scientific Research in University of Medicine and Pharmacy “Victor Babes”, Timisoara, Romania, October 31st, 2018 (25/31.10.2018), the Balearic Islands Ethics Committee, Mallorca, Spain, February 13th, 2019 (IB 3814/18 PI), and the Research Ethics Committee, Stockholm, Sweden, December 11th, 2018 (2018/2082–31/1). All parents/caregivers provided written informed consent for participation in the RCT. In both the Wave 1 and Wave 2 interview studies, all participating parents/caregivers also provided verbal informed consent prior to each interview. All methods were performed in accordance with the relevant guidelines and regulation.
: Not applicable.
: The authors declare that they have no competing interests.